The importance of intestinal residence time of absorption enhancer on drug absorption and implication on formulative considerations

International Journal of Pharmaceutics

Volumn 176, Issue 1, 1998, Pages 21-30

  Baluom, Muhammad ^a   Friedman, Michael ^a   Rubinstein, Abraham ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Absorption; Absorption enhancement; Cefazoline; EDTA; HPMC; Ibuprofen; In vivo analysis; Sodium decanoate; Sodium dodecyl sulphate; Synchronous release

Indexed keywords

CEFAZOLIN; DECANOIC ACID; DODECYL SULFATE SODIUM; EDETIC ACID; HYDROXYPROPYLMETHYLCELLULOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISSOLUTION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG RELEASE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; RAT; TABLET;

EID: 0031757846     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00288-9     Document Type: Article

References (16)

1. Anderberg E.K., Lindmark T., Arturrsson P. Sodium caprate elicits dilatation in human intestinal tight junctions and enhances drug absorption by the paracellular route. Pharm. Res. 10:1993;857-864.
2. Baluom M., Friedman D.I., Rubinstein A. Calcitonin absorption enhancement in the GI tract of the rat by carbopol containing submicron emulsions. Int. J. Pharm. 154:1997;235-243.
3. Catellani P., Vaona G., Plazzi P., Colombo P. Compressed matrices: formulation and drug release kinetics. Acta Pharm. Technol. 34:1988;38-41.
4. Colombo P., Gazzaniga A., Caramella C., Conte U., Manna A.L. In vitro programmable zero-order release drug delivey system. Acta Pharm. Technol. 33:1987;15-20.
5. Hochman J., Artursson P. Mechanism of absorption enhancement and tight junction regulation. J. Control. Release. 29:1994;253-267.
6. Hunter J., Hirst B.H. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption. Adv. Drug Del. Rev. 25:1997;129-157.
7. Kimura T., Sato K., Sugimoto K., Tao R., Murakami T., Kurosaki Y., Nakayama T. Oral administration of insulin as poly(vinyl alcohol)-gel spheres in diabetic rats. Biol. Pharm. Bull. 19:1996;897-900.
8. Muranishi, S., 1990. Absorption enhancers. Crit. Rev. Ther. Drug Carriers Syst. 7, 1-33.
9. Muranishi, S., 1985. Modification of of intestinal absorption of drugs by lipoidal adjuvants. Pharm. Res. 108-118.
10. Shameen M., Katori N., Aoyagi N., Kojima S. Oral solid controlled release dosage forms: role of GI-mechanical destructive forces and colonic release in drug absorption under fasted and fed conditions in humans. Pharm. Res. 12:1995;1049-1054.
11. Sintov A., Simberg M., Rubinstein A. Absorption enhancement of captopril in the rat colon as a putative method for capropril delivery by extended release formulations. Int. J. Pharm. 143:1996;101-106.
12. Swenson E.S., Milisen W.B., Curatolo W. Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility. Pharm. Res. 11:1994;1132-1142.
13. Tirosh B., Baluom M., Nassar T., Friedman M., Rubinstein A. The effect of Eudragit RL-100 on the mechanical and mucoadhesion properties of polycarbophil dosage forms. J. Control. Release. 45:1997;57-64.
14. van Hoogdalem E.J., Stijnen A.M., De Boer A.G., Breimer D.D. Rate-controlled absorption enhancement of rectally administered cefazolin in rats by a glyceride mixture (MGK). J. Pharm. Pharmacol. 40:1988;329-332.
15. Wacher V.J., Salphati L., Benet L.Z. Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv. Drug Del. Rev. 20:1996;99-112.
16. Yamamoto A., Uchiyama T., Nishikawa R., Fujita T., Muranishi S. Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane. J. Pharm. Pharmacol. 48:1996;1285-1289.